7 alpha-hydroxy-4-cholesten-3-one and Cystic Fibrosis

7 alpha-hydroxy-4-cholesten-3-one has been researched along with Cystic Fibrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berkers, G; Bodewes, FAJA; de Jonge, HR; Doktorova, M; Houwen, RHJ; Jonker, JW; van de Peppel, IP; Verkade, HJ	1

Other Studies

1 other study(ies) available for 7 alpha-hydroxy-4-cholesten-3-one and Cystic Fibrosis

Article	Year
IVACAFTOR restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2019, Volume: 18, Issue:2 Topics: Adolescent; Adult; Aminophenols; Bile Acids and Salts; Biological Availability; Child; Chloride Channel Agonists; Cholestenones; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Enterohepatic Circulation; Female; Fibroblast Growth Factors; Homeostasis; Humans; Male; Mutation; Netherlands; Quinolones	2019

Article

Year

IVACAFTOR restores FGF19 regulated bile acid homeostasis in cystic fibrosis patients with an S1251N or a G551D gating mutation.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2019, Volume: 18, Issue:2

Topics: Adolescent; Adult; Aminophenols; Bile Acids and Salts; Biological Availability; Child; Chloride Channel Agonists; Cholestenones; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Enterohepatic Circulation; Female; Fibroblast Growth Factors; Homeostasis; Humans; Male; Mutation; Netherlands; Quinolones

2019